ReleaseWire Connect

An investigation on behalf of investors of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares over potential securities laws violations by Vanda Pharmaceuticals Inc. and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors, who purchased shares of Medtronic, Inc. (NYSE:MDT) between December 2010 and June 2011, was announced concerning potential securities laws violations by Medtronic and certain of its directors and officers in connection certain financial statements.

An investigation for investors in Tetra Tech, Inc. (NASDAQ:TTEK) shares over potential securities laws violations by Tetra Tech, Inc. (NASDAQ:TTEK was announced and Tetra Tech, Inc. (NASDAQ:TTEK stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

An investigation on behalf of current long-term stockholders of shares of Vocera Communications Inc (NYSE:VCRA) was announced concerning whether certain Vocera Communications officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investigation on behalf of investors, who purchased shares of CafePress Inc (NASDAQ:PRSS) between March 28, 2012 and July 30, 2012, was announced concerning potential securities laws violations by CafePress and certain of its directors and officers in connection certain financial statements that were made between March 28, 2012 and July 30, 2012.

An investigation on behalf of investors of Liberty Silver Corp (OTCMKTS:LBSV) shares over potential securities laws violations by Liberty Silver Corp and certain of its directors and officers in connection certain financial statements was announced .

An investigation on behalf of investors, who currently hold NYSE:CTL shares and continuously have held those shares since at least early 2012, was announced concerning whether certain directors and officers of CenturyLink, Inc. (NYSE:CTL) breached their fiduciary duties in connection with certain statements that were made between August 8, 2012 and February 14, 2013.

An investigation on behalf of current long-term stockholders of shares of Cell Therapeutics Inc (NASDAQ:CTIC) was announced concerning whether certain Cell Therapeutics officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investigation on behalf of current long-term stockholders of shares of China Biologic Products Inc (NASDAQ:CBPO) was announced concerning whether certain China Biologic Products officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investigation on behalf of current long-term stockholders of shares of Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) was announced concerning whether certain Navidea Biopharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements.